A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to nAMD
Related studies linked through entity extraction aliases.
Safety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD).
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
Multicenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients With nAMD
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)
- Status
- RECRUITING
- Phase
- PHASE3
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
- Status
- RECRUITING
- Phase
- PHASE3
Targeted Fluorescence Imaging in AMD
- Status
- COMPLETED
- Phase
- PHASE1
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3